Total Laryngectomy
3
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Atos MedicalSweden - Horby
4 programs2
1
Provox Vega Voice Prosthesis 22.5 FrPhase 2
Provox Xtra HMEPhase 11 trial
Provox Xtra Heat and Moisture ExchangerPhase 1
Provox Vega Voice Prosthesis 20 FrN/A
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Atos MedicalProvox Xtra HME
Clinical Trials (1)
Total enrollment: 20 patients across 1 trials
Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy
Start: Jul 2009Est. completion: Aug 200920 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.